FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Rifampin Injection

  • U.S. Food and Drug Administration
  • August 20, 2026
  • ID: shortage-rifampin-injection-mylan-institutional-a-viatris-company-67457-445-60

Drug Shortage Details

Generic NameRifampin Injection
Manufacturer / CompanyMylan Institutional, a Viatris Company
Therapeutic CategoryAnti-Infective
Availability StatusUnavailable
Status (FDA list)Current
NDC Package Code67457-445-60
Presentation & Dosage Form

Rifampin, Injection, 600 mg (NDC 67457-445-60)

Manufacturer Contact Info

800-796-9526


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.